nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisatracurium Besylate—Skin disorder—Ifosfamide—hematologic cancer	0.000666	0.000666	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Melphalan—hematologic cancer	0.000666	0.000666	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—hematologic cancer	0.000657	0.000657	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Vincristine—hematologic cancer	0.000655	0.000655	CcSEcCtD
Cisatracurium Besylate—Erythema—Prednisolone—hematologic cancer	0.000654	0.000654	CcSEcCtD
Cisatracurium Besylate—Hypotension—Carmustine—hematologic cancer	0.000654	0.000654	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Mitoxantrone—hematologic cancer	0.000651	0.000651	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Irinotecan—hematologic cancer	0.000651	0.000651	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Thalidomide—hematologic cancer	0.00065	0.00065	CcSEcCtD
Cisatracurium Besylate—Hypotension—Alitretinoin—hematologic cancer	0.000648	0.000648	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Lenalidomide—hematologic cancer	0.000647	0.000647	CcSEcCtD
Cisatracurium Besylate—Urticaria—Bortezomib—hematologic cancer	0.000642	0.000642	CcSEcCtD
Cisatracurium Besylate—Hypotension—Ifosfamide—hematologic cancer	0.000641	0.000641	CcSEcCtD
Cisatracurium Besylate—Pruritus—Melphalan—hematologic cancer	0.000639	0.000639	CcSEcCtD
Cisatracurium Besylate—Rash—Nilotinib—hematologic cancer	0.000639	0.000639	CcSEcCtD
Cisatracurium Besylate—Bradycardia—Betamethasone—hematologic cancer	0.000638	0.000638	CcSEcCtD
Cisatracurium Besylate—Bradycardia—Dexamethasone—hematologic cancer	0.000638	0.000638	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Nilotinib—hematologic cancer	0.000638	0.000638	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Irinotecan—hematologic cancer	0.000638	0.000638	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Hydroxyurea—hematologic cancer	0.000638	0.000638	CcSEcCtD
Cisatracurium Besylate—Anaphylactoid reaction—Epirubicin—hematologic cancer	0.000638	0.000638	CcSEcCtD
Cisatracurium Besylate—Urticaria—Bleomycin—hematologic cancer	0.000637	0.000637	CcSEcCtD
Cisatracurium Besylate—Rash—Imatinib—hematologic cancer	0.000635	0.000635	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Mitoxantrone—hematologic cancer	0.000635	0.000635	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Imatinib—hematologic cancer	0.000635	0.000635	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Gemcitabine—hematologic cancer	0.000634	0.000634	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Mitoxantrone—hematologic cancer	0.000632	0.000632	CcSEcCtD
Cisatracurium Besylate—Convulsion—Cisplatin—hematologic cancer	0.000627	0.000627	CcSEcCtD
Cisatracurium Besylate—Urticaria—Vinorelbine—hematologic cancer	0.000627	0.000627	CcSEcCtD
Cisatracurium Besylate—Hypotension—Vincristine—hematologic cancer	0.000624	0.000624	CcSEcCtD
Cisatracurium Besylate—Rash—Cladribine—hematologic cancer	0.000624	0.000624	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Carmustine—hematologic cancer	0.000624	0.000624	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Cladribine—hematologic cancer	0.000624	0.000624	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Gemcitabine—hematologic cancer	0.000622	0.000622	CcSEcCtD
Cisatracurium Besylate—Pruritus—Lenalidomide—hematologic cancer	0.000621	0.000621	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Alitretinoin—hematologic cancer	0.000618	0.000618	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Gemcitabine—hematologic cancer	0.000616	0.000616	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—hematologic cancer	0.000612	0.000612	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Ifosfamide—hematologic cancer	0.000611	0.000611	CcSEcCtD
Cisatracurium Besylate—Hypotension—Mitoxantrone—hematologic cancer	0.000608	0.000608	CcSEcCtD
Cisatracurium Besylate—Hypotension—Irinotecan—hematologic cancer	0.000608	0.000608	CcSEcCtD
Cisatracurium Besylate—Erythema—Triamcinolone—hematologic cancer	0.000602	0.000602	CcSEcCtD
Cisatracurium Besylate—Urticaria—Thiotepa—hematologic cancer	0.000599	0.000599	CcSEcCtD
Cisatracurium Besylate—Angioedema—Prednisolone—hematologic cancer	0.000598	0.000598	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Bortezomib—hematologic cancer	0.000595	0.000595	CcSEcCtD
Cisatracurium Besylate—Hypotension—Gemcitabine—hematologic cancer	0.000592	0.000592	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Cisplatin—hematologic cancer	0.000591	0.000591	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Bleomycin—hematologic cancer	0.000591	0.000591	CcSEcCtD
Cisatracurium Besylate—Anaphylactoid reaction—Doxorubicin—hematologic cancer	0.00059	0.00059	CcSEcCtD
Cisatracurium Besylate—Cardiac arrest—Epirubicin—hematologic cancer	0.000587	0.000587	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Vinorelbine—hematologic cancer	0.000581	0.000581	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Irinotecan—hematologic cancer	0.00058	0.00058	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Mitoxantrone—hematologic cancer	0.00058	0.00058	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Cisplatin—hematologic cancer	0.00058	0.00058	CcSEcCtD
Cisatracurium Besylate—Urticaria—Thalidomide—hematologic cancer	0.000579	0.000579	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Cisplatin—hematologic cancer	0.000577	0.000577	CcSEcCtD
Cisatracurium Besylate—Convulsion—Etoposide—hematologic cancer	0.000575	0.000575	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Cisplatin—hematologic cancer	0.000574	0.000574	CcSEcCtD
Cisatracurium Besylate—Hypertension—Etoposide—hematologic cancer	0.000573	0.000573	CcSEcCtD
Cisatracurium Besylate—Pruritus—Bortezomib—hematologic cancer	0.000572	0.000572	CcSEcCtD
Cisatracurium Besylate—Rash—Melphalan—hematologic cancer	0.00057	0.00057	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Melphalan—hematologic cancer	0.000569	0.000569	CcSEcCtD
Cisatracurium Besylate—Angiopathy—Dexamethasone—hematologic cancer	0.000569	0.000569	CcSEcCtD
Cisatracurium Besylate—Angiopathy—Betamethasone—hematologic cancer	0.000569	0.000569	CcSEcCtD
Cisatracurium Besylate—Pruritus—Bleomycin—hematologic cancer	0.000567	0.000567	CcSEcCtD
Cisatracurium Besylate—Convulsion—Prednisolone—hematologic cancer	0.000567	0.000567	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Gemcitabine—hematologic cancer	0.000565	0.000565	CcSEcCtD
Cisatracurium Besylate—Hypertension—Prednisolone—hematologic cancer	0.000565	0.000565	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—hematologic cancer	0.000561	0.000561	CcSEcCtD
Cisatracurium Besylate—Pruritus—Vinorelbine—hematologic cancer	0.000558	0.000558	CcSEcCtD
Cisatracurium Besylate—Bradycardia—Prednisone—hematologic cancer	0.000556	0.000556	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Thiotepa—hematologic cancer	0.000555	0.000555	CcSEcCtD
Cisatracurium Besylate—Rash—Lenalidomide—hematologic cancer	0.000554	0.000554	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Lenalidomide—hematologic cancer	0.000553	0.000553	CcSEcCtD
Cisatracurium Besylate—Hypotension—Cisplatin—hematologic cancer	0.000552	0.000552	CcSEcCtD
Cisatracurium Besylate—Urticaria—Alitretinoin—hematologic cancer	0.000551	0.000551	CcSEcCtD
Cisatracurium Besylate—Angioedema—Triamcinolone—hematologic cancer	0.00055	0.00055	CcSEcCtD
Cisatracurium Besylate—Rash—Hydroxyurea—hematologic cancer	0.000546	0.000546	CcSEcCtD
Cisatracurium Besylate—Erythema—Dexamethasone—hematologic cancer	0.000546	0.000546	CcSEcCtD
Cisatracurium Besylate—Erythema—Betamethasone—hematologic cancer	0.000546	0.000546	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Hydroxyurea—hematologic cancer	0.000546	0.000546	CcSEcCtD
Cisatracurium Besylate—Muscular weakness—Epirubicin—hematologic cancer	0.000545	0.000545	CcSEcCtD
Cisatracurium Besylate—Urticaria—Ifosfamide—hematologic cancer	0.000545	0.000545	CcSEcCtD
Cisatracurium Besylate—Cardiac arrest—Doxorubicin—hematologic cancer	0.000543	0.000543	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Etoposide—hematologic cancer	0.000541	0.000541	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Thalidomide—hematologic cancer	0.000537	0.000537	CcSEcCtD
Cisatracurium Besylate—Connective tissue disorder—Prednisone—hematologic cancer	0.000537	0.000537	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Prednisolone—hematologic cancer	0.000534	0.000534	CcSEcCtD
Cisatracurium Besylate—Pruritus—Thiotepa—hematologic cancer	0.000533	0.000533	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Etoposide—hematologic cancer	0.000528	0.000528	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Cisplatin—hematologic cancer	0.000527	0.000527	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Etoposide—hematologic cancer	0.000526	0.000526	CcSEcCtD
Cisatracurium Besylate—Convulsion—Triamcinolone—hematologic cancer	0.000521	0.000521	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Prednisolone—hematologic cancer	0.000521	0.000521	CcSEcCtD
Cisatracurium Besylate—Hypertension—Triamcinolone—hematologic cancer	0.000519	0.000519	CcSEcCtD
Cisatracurium Besylate—Urticaria—Mitoxantrone—hematologic cancer	0.000517	0.000517	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Carmustine—hematologic cancer	0.000516	0.000516	CcSEcCtD
Cisatracurium Besylate—Pruritus—Thalidomide—hematologic cancer	0.000516	0.000516	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Alitretinoin—hematologic cancer	0.000511	0.000511	CcSEcCtD
Cisatracurium Besylate—Rash—Bortezomib—hematologic cancer	0.00051	0.00051	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Bortezomib—hematologic cancer	0.000509	0.000509	CcSEcCtD
Cisatracurium Besylate—Flushing—Prednisone—hematologic cancer	0.000507	0.000507	CcSEcCtD
Cisatracurium Besylate—Hypotension—Etoposide—hematologic cancer	0.000506	0.000506	CcSEcCtD
Cisatracurium Besylate—Rash—Bleomycin—hematologic cancer	0.000506	0.000506	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Bleomycin—hematologic cancer	0.000505	0.000505	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Ifosfamide—hematologic cancer	0.000505	0.000505	CcSEcCtD
Cisatracurium Besylate—Muscular weakness—Doxorubicin—hematologic cancer	0.000504	0.000504	CcSEcCtD
Cisatracurium Besylate—Angioedema—Betamethasone—hematologic cancer	0.000499	0.000499	CcSEcCtD
Cisatracurium Besylate—Angioedema—Dexamethasone—hematologic cancer	0.000499	0.000499	CcSEcCtD
Cisatracurium Besylate—Rash—Vinorelbine—hematologic cancer	0.000498	0.000498	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Vinorelbine—hematologic cancer	0.000497	0.000497	CcSEcCtD
Cisatracurium Besylate—Angiopathy—Prednisone—hematologic cancer	0.000496	0.000496	CcSEcCtD
Cisatracurium Besylate—Immune system disorder—Prednisone—hematologic cancer	0.000493	0.000493	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Vincristine—hematologic cancer	0.000492	0.000492	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Triamcinolone—hematologic cancer	0.000491	0.000491	CcSEcCtD
Cisatracurium Besylate—Pruritus—Alitretinoin—hematologic cancer	0.000491	0.000491	CcSEcCtD
Cisatracurium Besylate—Pruritus—Ifosfamide—hematologic cancer	0.000485	0.000485	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Etoposide—hematologic cancer	0.000483	0.000483	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Mitoxantrone—hematologic cancer	0.00048	0.00048	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Irinotecan—hematologic cancer	0.00048	0.00048	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Triamcinolone—hematologic cancer	0.000479	0.000479	CcSEcCtD
Cisatracurium Besylate—Erythema—Prednisone—hematologic cancer	0.000475	0.000475	CcSEcCtD
Cisatracurium Besylate—Rash—Thiotepa—hematologic cancer	0.000475	0.000475	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Thiotepa—hematologic cancer	0.000475	0.000475	CcSEcCtD
Cisatracurium Besylate—Convulsion—Dexamethasone—hematologic cancer	0.000473	0.000473	CcSEcCtD
Cisatracurium Besylate—Convulsion—Betamethasone—hematologic cancer	0.000473	0.000473	CcSEcCtD
Cisatracurium Besylate—Hypertension—Dexamethasone—hematologic cancer	0.000471	0.000471	CcSEcCtD
Cisatracurium Besylate—Hypertension—Betamethasone—hematologic cancer	0.000471	0.000471	CcSEcCtD
Cisatracurium Besylate—Rash—Thalidomide—hematologic cancer	0.00046	0.00046	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Thalidomide—hematologic cancer	0.000459	0.000459	CcSEcCtD
Cisatracurium Besylate—Pruritus—Gemcitabine—hematologic cancer	0.000449	0.000449	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Dexamethasone—hematologic cancer	0.000446	0.000446	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Betamethasone—hematologic cancer	0.000446	0.000446	CcSEcCtD
Cisatracurium Besylate—Rash—Carmustine—hematologic cancer	0.000441	0.000441	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Carmustine—hematologic cancer	0.000441	0.000441	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Triamcinolone—hematologic cancer	0.000438	0.000438	CcSEcCtD
Cisatracurium Besylate—Rash—Alitretinoin—hematologic cancer	0.000437	0.000437	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Dexamethasone—hematologic cancer	0.000437	0.000437	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Betamethasone—hematologic cancer	0.000437	0.000437	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Alitretinoin—hematologic cancer	0.000437	0.000437	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Cisplatin—hematologic cancer	0.000435	0.000435	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Dexamethasone—hematologic cancer	0.000435	0.000435	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Betamethasone—hematologic cancer	0.000435	0.000435	CcSEcCtD
Cisatracurium Besylate—Bradycardia—Epirubicin—hematologic cancer	0.000435	0.000435	CcSEcCtD
Cisatracurium Besylate—Angioedema—Prednisone—hematologic cancer	0.000434	0.000434	CcSEcCtD
Cisatracurium Besylate—Rash—Ifosfamide—hematologic cancer	0.000432	0.000432	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Ifosfamide—hematologic cancer	0.000432	0.000432	CcSEcCtD
Cisatracurium Besylate—Urticaria—Etoposide—hematologic cancer	0.00043	0.00043	CcSEcCtD
Cisatracurium Besylate—Urticaria—Prednisolone—hematologic cancer	0.000424	0.000424	CcSEcCtD
Cisatracurium Besylate—Rash—Vincristine—hematologic cancer	0.000421	0.000421	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Vincristine—hematologic cancer	0.000421	0.000421	CcSEcCtD
Cisatracurium Besylate—Connective tissue disorder—Epirubicin—hematologic cancer	0.00042	0.00042	CcSEcCtD
Cisatracurium Besylate—Hypotension—Betamethasone—hematologic cancer	0.000416	0.000416	CcSEcCtD
Cisatracurium Besylate—Hypotension—Dexamethasone—hematologic cancer	0.000416	0.000416	CcSEcCtD
Cisatracurium Besylate—Angiopathy—Methotrexate—hematologic cancer	0.000414	0.000414	CcSEcCtD
Cisatracurium Besylate—Immune system disorder—Methotrexate—hematologic cancer	0.000412	0.000412	CcSEcCtD
Cisatracurium Besylate—Convulsion—Prednisone—hematologic cancer	0.000412	0.000412	CcSEcCtD
Cisatracurium Besylate—Mediastinal disorder—Methotrexate—hematologic cancer	0.000411	0.000411	CcSEcCtD
Cisatracurium Besylate—Hypertension—Prednisone—hematologic cancer	0.00041	0.00041	CcSEcCtD
Cisatracurium Besylate—Rash—Irinotecan—hematologic cancer	0.00041	0.00041	CcSEcCtD
Cisatracurium Besylate—Rash—Mitoxantrone—hematologic cancer	0.00041	0.00041	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Irinotecan—hematologic cancer	0.00041	0.00041	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Mitoxantrone—hematologic cancer	0.00041	0.00041	CcSEcCtD
Cisatracurium Besylate—Bradycardia—Doxorubicin—hematologic cancer	0.000402	0.000402	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	0.000402	0.000402	CcSEcCtD
Cisatracurium Besylate—Rash—Gemcitabine—hematologic cancer	0.0004	0.0004	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Gemcitabine—hematologic cancer	0.000399	0.000399	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Etoposide—hematologic cancer	0.000399	0.000399	CcSEcCtD
Cisatracurium Besylate—Erythema—Methotrexate—hematologic cancer	0.000397	0.000397	CcSEcCtD
Cisatracurium Besylate—Flushing—Epirubicin—hematologic cancer	0.000396	0.000396	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Prednisolone—hematologic cancer	0.000393	0.000393	CcSEcCtD
Cisatracurium Besylate—Urticaria—Triamcinolone—hematologic cancer	0.00039	0.00039	CcSEcCtD
Cisatracurium Besylate—Connective tissue disorder—Doxorubicin—hematologic cancer	0.000388	0.000388	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Prednisone—hematologic cancer	0.000388	0.000388	CcSEcCtD
Cisatracurium Besylate—Angiopathy—Epirubicin—hematologic cancer	0.000388	0.000388	CcSEcCtD
Cisatracurium Besylate—Immune system disorder—Epirubicin—hematologic cancer	0.000386	0.000386	CcSEcCtD
Cisatracurium Besylate—Mediastinal disorder—Epirubicin—hematologic cancer	0.000385	0.000385	CcSEcCtD
Cisatracurium Besylate—Pruritus—Etoposide—hematologic cancer	0.000383	0.000383	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Prednisone—hematologic cancer	0.000381	0.000381	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Prednisone—hematologic cancer	0.000379	0.000379	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Prednisone—hematologic cancer	0.000377	0.000377	CcSEcCtD
Cisatracurium Besylate—Rash—Cisplatin—hematologic cancer	0.000373	0.000373	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Cisplatin—hematologic cancer	0.000372	0.000372	CcSEcCtD
Cisatracurium Besylate—Erythema—Epirubicin—hematologic cancer	0.000372	0.000372	CcSEcCtD
Cisatracurium Besylate—Flushing—Doxorubicin—hematologic cancer	0.000367	0.000367	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Triamcinolone—hematologic cancer	0.000362	0.000362	CcSEcCtD
Cisatracurium Besylate—Angiopathy—Doxorubicin—hematologic cancer	0.000359	0.000359	CcSEcCtD
Cisatracurium Besylate—Immune system disorder—Doxorubicin—hematologic cancer	0.000357	0.000357	CcSEcCtD
Cisatracurium Besylate—Mediastinal disorder—Doxorubicin—hematologic cancer	0.000356	0.000356	CcSEcCtD
Cisatracurium Besylate—Urticaria—Dexamethasone—hematologic cancer	0.000354	0.000354	CcSEcCtD
Cisatracurium Besylate—Urticaria—Betamethasone—hematologic cancer	0.000354	0.000354	CcSEcCtD
Cisatracurium Besylate—Pruritus—Triamcinolone—hematologic cancer	0.000347	0.000347	CcSEcCtD
Cisatracurium Besylate—Convulsion—Methotrexate—hematologic cancer	0.000344	0.000344	CcSEcCtD
Cisatracurium Besylate—Erythema—Doxorubicin—hematologic cancer	0.000344	0.000344	CcSEcCtD
Cisatracurium Besylate—Rash—Etoposide—hematologic cancer	0.000341	0.000341	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Etoposide—hematologic cancer	0.000341	0.000341	CcSEcCtD
Cisatracurium Besylate—Rash—Prednisolone—hematologic cancer	0.000337	0.000337	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Prednisolone—hematologic cancer	0.000336	0.000336	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	0.000336	0.000336	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Methotrexate—hematologic cancer	0.000324	0.000324	CcSEcCtD
Cisatracurium Besylate—Convulsion—Epirubicin—hematologic cancer	0.000322	0.000322	CcSEcCtD
Cisatracurium Besylate—Hypertension—Epirubicin—hematologic cancer	0.000321	0.000321	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Methotrexate—hematologic cancer	0.000318	0.000318	CcSEcCtD
Cisatracurium Besylate—Pruritus—Betamethasone—hematologic cancer	0.000315	0.000315	CcSEcCtD
Cisatracurium Besylate—Pruritus—Dexamethasone—hematologic cancer	0.000315	0.000315	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Methotrexate—hematologic cancer	0.000315	0.000315	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	0.000314	0.000314	CcSEcCtD
Cisatracurium Besylate—Rash—Triamcinolone—hematologic cancer	0.00031	0.00031	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Triamcinolone—hematologic cancer	0.000309	0.000309	CcSEcCtD
Cisatracurium Besylate—Urticaria—Prednisone—hematologic cancer	0.000308	0.000308	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Epirubicin—hematologic cancer	0.000303	0.000303	CcSEcCtD
Cisatracurium Besylate—Hypotension—Methotrexate—hematologic cancer	0.000303	0.000303	CcSEcCtD
Cisatracurium Besylate—Convulsion—Doxorubicin—hematologic cancer	0.000298	0.000298	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Epirubicin—hematologic cancer	0.000298	0.000298	CcSEcCtD
Cisatracurium Besylate—Hypertension—Doxorubicin—hematologic cancer	0.000297	0.000297	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Epirubicin—hematologic cancer	0.000296	0.000296	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Epirubicin—hematologic cancer	0.000295	0.000295	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	0.000291	0.000291	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Methotrexate—hematologic cancer	0.000289	0.000289	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Prednisone—hematologic cancer	0.000286	0.000286	CcSEcCtD
Cisatracurium Besylate—Hypotension—Epirubicin—hematologic cancer	0.000284	0.000284	CcSEcCtD
Cisatracurium Besylate—Rash—Dexamethasone—hematologic cancer	0.000281	0.000281	CcSEcCtD
Cisatracurium Besylate—Rash—Betamethasone—hematologic cancer	0.000281	0.000281	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Doxorubicin—hematologic cancer	0.000281	0.000281	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Dexamethasone—hematologic cancer	0.000281	0.000281	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Betamethasone—hematologic cancer	0.000281	0.000281	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Doxorubicin—hematologic cancer	0.000275	0.000275	CcSEcCtD
Cisatracurium Besylate—Pruritus—Prednisone—hematologic cancer	0.000275	0.000275	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Doxorubicin—hematologic cancer	0.000274	0.000274	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Doxorubicin—hematologic cancer	0.000273	0.000273	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Epirubicin—hematologic cancer	0.000271	0.000271	CcSEcCtD
Cisatracurium Besylate—Hypotension—Doxorubicin—hematologic cancer	0.000262	0.000262	CcSEcCtD
Cisatracurium Besylate—Urticaria—Methotrexate—hematologic cancer	0.000258	0.000258	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Doxorubicin—hematologic cancer	0.00025	0.00025	CcSEcCtD
Cisatracurium Besylate—Rash—Prednisone—hematologic cancer	0.000245	0.000245	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Prednisone—hematologic cancer	0.000244	0.000244	CcSEcCtD
Cisatracurium Besylate—Urticaria—Epirubicin—hematologic cancer	0.000241	0.000241	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Methotrexate—hematologic cancer	0.000239	0.000239	CcSEcCtD
Cisatracurium Besylate—Pruritus—Methotrexate—hematologic cancer	0.000229	0.000229	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Epirubicin—hematologic cancer	0.000224	0.000224	CcSEcCtD
Cisatracurium Besylate—Urticaria—Doxorubicin—hematologic cancer	0.000223	0.000223	CcSEcCtD
Cisatracurium Besylate—Pruritus—Epirubicin—hematologic cancer	0.000215	0.000215	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Doxorubicin—hematologic cancer	0.000207	0.000207	CcSEcCtD
Cisatracurium Besylate—Rash—Methotrexate—hematologic cancer	0.000204	0.000204	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Methotrexate—hematologic cancer	0.000204	0.000204	CcSEcCtD
Cisatracurium Besylate—Pruritus—Doxorubicin—hematologic cancer	0.000199	0.000199	CcSEcCtD
Cisatracurium Besylate—Rash—Epirubicin—hematologic cancer	0.000191	0.000191	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Epirubicin—hematologic cancer	0.000191	0.000191	CcSEcCtD
Cisatracurium Besylate—Rash—Doxorubicin—hematologic cancer	0.000177	0.000177	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Doxorubicin—hematologic cancer	0.000177	0.000177	CcSEcCtD
